Thomas J Schnitzer

Grants

Grants per year 2002 2004 2005 2006 2007 2008 2009 2010 2012 2015 2016 2019 2020 2025

• 16 Active
• 85 Finished

Grants per year

Search results

• Finished

  Transcranial Magnetic Stimulation to Enhance Cortical-Hippocampal Functional Connectivity as a Novel Means for Relieving Chronic OA Pain

  Apkarian, A., Schnitzer, T. J. & Voss, J. L.

  Pfizer Inc.

  5/24/21 → 5/23/22

  Project: Research project

• Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

  Schnitzer, T. J.

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  5/14/19 → 5/14/22

  Project: Research project

• Prot #FX006-2018-015: A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis

  Schnitzer, T. J.

  Flexion Therapeutics, Inc.

  2/6/19 → 2/6/22

  Project: Research project

• Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

  Schnitzer, T. J.

  Medpace Clinical Research LLC, Galapagos NV

  12/4/18 → 12/4/21

  Project: Research project

• Prot #KF7013-03: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

  Schnitzer, T. J.

  Worldwide Clinical Trials, Inc., Grunenthal GmbH

  1/17/17 → 1/17/22

  Project: Research project

• Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy

  Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/16 → 3/29/19

  Project: Research project

  • Bone Mass 100%
  • Bone Strength 66%
  • bones 66%
  • Teriparatide 50%
  • Fracture 50%

• Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/2/16 → 8/2/19

  Project: Research project

• Cortico-striatal plasticity in the transition to chronic pain

  Apkarian, A., Griffith, J. W., Martina, M., Parrish, T. B., Procissi, D., Schnitzer, T. J. & Surmeier Jr, D. J.

  National Institute of Dental and Craniofacial Research

  7/1/16 → 12/31/18

  Project: Research project

• Brain mechanisms for clinical placebo in chronic pain

  Apkarian, A., Cella, D., Gershon, R., Parrish, T. B., Schnitzer, T. J. & Griffith, J. W.

  National Center for Complementary and Integrative Health

  6/1/16 → 5/31/18

  Project: Research project

• Prot #AXS02-K301: COAST-1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study- A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Kn

  Schnitzer, T. J.

  Axsome Therapeutics, Inc.

  3/15/16 → 11/30/20

  Project: Research project

• Prot #AXS02-301: CREATE-1 Study: CRPS Treatment Evaluation 1 Study: A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional

  Schnitzer, T. J.

  Axsome Therapeutics, Inc.

  3/10/16 → 3/10/19

  Project: Research project

• Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

  3/10/16 → 4/15/21

  Project: Research project

• Functional Performance Evaluation of the Northwestern University Flexible Sub-Ischial Vacuum (NU-FlexSIV) Socket for Persons with Transfemoral Amputation

  Fatone, S. & Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/15 → 9/29/20

  Project: Research project

  • Amputation 100%
  • Prosthesis 60%
  • Limb 43%
  • limbs 43%
  • Pelvis 40%

• Prot #A4091064: A Phase 3, Multicenter, Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

  Schnitzer, T. J.

  inVentiv Health Clinical, Pfizer Inc.

  9/11/15 → 9/11/19

  Project: Research project

• Prot #A4091059: A Phase 3, Randomized, Double Blind, Placebo and Active Controlled, Multicenter, Parallel Group Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects with Chronic Low Back Pain

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  9/11/15 → 9/11/21

  Project: Research project

• Prot #A4091058: A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/25/15 → 8/31/22

  Project: Research project

• Prot #42160443PAI3001: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Adjunctive Therapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  inVentiv Health Clinical, Janssen Research & Development, LLC

  7/22/15 → 7/22/18

  Project: Research project

• Prot #42160443PAI3002: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  inVentiv Health Clinical, Janssen Research & Development, LLC

  7/22/15 → 7/22/18

  Project: Research project

• Prot #R475-PN-1227: A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of REGN475 in Patients with Osteoarthritis of the Knee/Hip who have an Inadequate Response to NSAID and Opioid Therapy

  Schnitzer, T. J.

  Parexel, Regeneron Pharmaceuticals, Inc.

  6/22/15 → 6/22/18

  Project: Research project

• Prot #M14-171: A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-981 to Placebo in Subjects with Erosive Hand Osteoarthritis

  Schnitzer, T. J.

  AbbVie Inc.

  4/7/15 → 4/7/18

  Project: Research project

• Prot #DS5565-A-E312: An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated with Fibromyalgia

  Schnitzer, T. J.

  INC Research, LLC, Daiichi Sankyo Development Ltd.

  1/8/15 → 9/8/16

  Project: Research project

• Prot #191622-145: BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

  Schnitzer, T. J.

  Allergan Sales, LLC

  12/12/14 → 1/31/17

  Project: Research project

• Prot #DS5565-A-E311: A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 in Subjects with Pain Associated with Fibromyalgia

  Schnitzer, T. J.

  INC Research, LLC, Daiichi Sankyo Development Ltd.

  12/9/14 → 12/9/17

  Project: Research project

• Prevention of Bone Loss after Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength and Use of Biomarkers to Guide Therapy

  Schnitzer, T. J. & Griffith, J. W.

  U.S. Army Medical Research and Materiel Command

  9/30/14 → 3/28/21

  Project: Research project

  • Spinal Cord Injury 100%
  • bones 53%
  • Osteolysis 50%
  • injuries 46%
  • spinal cord 46%

• Prot #M13-741: A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients with Knee Osteoarthritis

  Schnitzer, T. J.

  AbbVie Inc.

  5/20/14 → 5/20/18

  Project: Research project